An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:December 2014
Contact:XOMA Clinical Study Center
Phone:1-800-758-7063

Use our guide to learn which trials are right for you!

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of
pyoderma gangrenosum (PG).


Inclusion Criteria:

- A clinical diagnosis of classic pyoderma gangrenosum

- An active pyoderma gangrenosum ulcer

- Contraceptive measures adequate to prevent pregnancy during the study

Exclusion Criteria:

- Clinical evidence of acutely infected pyoderma gangrenosum

- History of allergic or anaphylactic reactions to monoclonal antibodies

- History of recurrent or chronic systemic infections

- Female subjects who are pregnant, planning to become pregnant, have recently
delivered, or are breast-feeding

Other protocol-defined inclusion/exclusion criteria may apply
We found this trial at
8
sites
?
mi
from
Bronx, NY
Click here to add this to my saved trials
?
mi
from
Benowa,
Click here to add this to my saved trials
?
mi
from
Henderson, NV
Click here to add this to my saved trials
?
mi
from
Macon, GA
Click here to add this to my saved trials
?
mi
from
Oceanside, CA
Click here to add this to my saved trials
?
mi
from
Rochester, NY
Click here to add this to my saved trials
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials